Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Petzold

Showing results (31-40 of 277) with videos related to

Pageof 28
Sort By:
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseasesJens Kuhle, Axel Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2020
Can stability of visual fixation be a measure for disability in multiple sclerosis?Alessandro Serra, Axel Petzold
Practical Neurology|November 20, 2025
Diagnosing optic neuritis in the changing landscape of diagnostic criteriaJosef Penkava, Axel Petzold
Neurocritical Care|March 16, 2007
H2O comaDorothea Stiefel, Axel Petzold
Neurocritical Care|July 30, 2013
Pain management in neurocritical careAxel Petzold, Armand Girbes
Stroke|January 7, 2006
High intracranial pressure, brain herniation and death in cerebral venous thrombosisAxel Petzold, Martin Smith
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing diseaseJens Kuhle, Axel Petzold
Journal of Neurology|May 24, 2013
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reportedAxel Petzold, Gordon T Plant
Autoimmunity Reviews|January 16, 2014
Diagnosis and classification of autoimmune optic neuropathyAxel Petzold, Gordon T Plant
Multiple Sclerosis International|January 15, 2013
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathiesAxel Petzold, Gordon T Plant
Pageof 28

Showing results (31-40 of 277) with videos related to

Sort By:
Pageof 28
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseasesJens Kuhle, Axel Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2020
Can stability of visual fixation be a measure for disability in multiple sclerosis?Alessandro Serra, Axel Petzold
Practical Neurology|November 20, 2025
Diagnosing optic neuritis in the changing landscape of diagnostic criteriaJosef Penkava, Axel Petzold
Neurocritical Care|March 16, 2007
H2O comaDorothea Stiefel, Axel Petzold
Neurocritical Care|July 30, 2013
Pain management in neurocritical careAxel Petzold, Armand Girbes
Stroke|January 7, 2006
High intracranial pressure, brain herniation and death in cerebral venous thrombosisAxel Petzold, Martin Smith
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing diseaseJens Kuhle, Axel Petzold
Journal of Neurology|May 24, 2013
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reportedAxel Petzold, Gordon T Plant
Autoimmunity Reviews|January 16, 2014
Diagnosis and classification of autoimmune optic neuropathyAxel Petzold, Gordon T Plant
Multiple Sclerosis International|January 15, 2013
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathiesAxel Petzold, Gordon T Plant
Pageof 28